Abstract

Although the burden of histoplasmosis in patients with advanced HIV has been the focus of detailed estimations, knowledge about invasive fungal infections in patients living with HIV in an Amazonian context is somewhat scattered. Our goal was thus to adopt a broader view integrating all invasive fungal infections diagnosed over a decade in French Guiana. All patients hospitalized at Cayenne hospital from 1 January 2009 to 31 December 2018 with a proven diagnosis of invasive fungal infection were included (n = 227). Histoplasmosis was the most common (48.2%), followed by Cryptococcus infection (26.3%), and pneumocystosis (12.5%). For cryptococcal infection, there was a discordance between the actual diagnosis of cryptococcal meningitis n = (26) and the isolated presence of antigen in the serum (n = 46). Among the latter when the information was available (n = 34), 21(65.6%) were treated with antifungals but not coded as cryptococcocosis. Most fungal infections were simultaneous to the discovery of HIV (38%) and were the AIDS-defining event (66%). The proportion of major invasive fungal infections appeared to remain stable over the course of the study, with a clear predominance of documented H. capsulatum infections. Until now, the focus of attention has been histoplasmosis, but such attention should not overshadow other less-studied invasive fungal infections.

Highlights

  • IntroductionFungal infections (FIs) represent an emerging health issue worldwide, and their contribution to the morbidity and mortality of persons living with HIV (PLWHIV) is still underestimated [1,2]

  • 227 patients living with HIV had a total of 274 invasive fungal infections, which represented for the study period 2.5 invasive fungal infection per 100 person-years

  • Invasive fungal infections among persons living with HIV (PLWHIV) in French Guiana remain constantly dominated by H. capsultatum infections

Read more

Summary

Introduction

Fungal infections (FIs) represent an emerging health issue worldwide, and their contribution to the morbidity and mortality of persons living with HIV (PLWHIV) is still underestimated [1,2]. The HIV epidemic is far from being controlled in many parts of the world, in emerging countries where endemic fungal diseases suffer from a lack of knowledge and availability of reliable diagnostic methods [4]. This is the case for histoplasmosis in South America, recognized as one of the first opportunistic infections at the AIDS stage, even before tuberculosis [5,6,7]. Azole resistance is an emerging problem, due to frequent exposure to azole anti-fungals and the emergence of non-albicans species with lower sensitivity to fluconazole [8]

Objectives
Methods
Results
Discussion
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call